Baylor College of Medicine Jan 10 2025 A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor, Houston Methodist Hospital and Texas Children's Hospital examined how molecular dynamics at the immune synapse – where CAR T cells bind to cancer cells – affect anticancer